Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GHDX

Genomic Health (GHDX) Stock Price, News & Analysis

Genomic Health logo

About Genomic Health Stock (NASDAQ:GHDX)

Advanced Chart

Key Stats

Today's Range
$63.44
$63.44
50-Day Range
$63.44
$69.79
52-Week Range
$50.77
$90.18
Volume
N/A
Average Volume
1.05 million shs
Market Capitalization
$2.38 billion
P/E Ratio
60.42
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GHDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genomic Health and its competitors with MarketBeat's FREE daily newsletter.

GHDX Stock News Headlines

Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
PanGenomic Health Announces CFO Transition
See More Headlines

GHDX Stock Analysis - Frequently Asked Questions

Genomic Health, Inc. (NASDAQ:GHDX) released its quarterly earnings data on Monday, November, 11th. The medical research company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.11. Genomic Health had a trailing twelve-month return on equity of 19.62% and a net margin of 12.81%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genomic Health investors own include Revance Therapeutics (RVNC), Horizon Therapeutics Public (HZNP), Illumina (ILMN), NVIDIA (NVDA), Ionis Pharmaceuticals (IONS), Vertex Pharmaceuticals (VRTX) and Exelixis (EXEL).

Company Calendar

Last Earnings
11/11/2019
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GHDX
CIK
1131324
Fax
N/A
Employees
829
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.05
Trailing P/E Ratio
60.42
Forward P/E Ratio
40.15
P/E Growth
N/A
Net Income
$25.68 million
Net Margins
12.81%
Pretax Margin
N/A
Return on Equity
19.62%
Return on Assets
14.89%

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
5.96
Quick Ratio
5.96

Sales & Book Value

Annual Sales
$394.11 million
Price / Sales
6.05
Cash Flow
$1.45 per share
Price / Cash Flow
43.76
Book Value
$7.48 per share
Price / Book
8.48

Miscellaneous

Outstanding Shares
37,590,000
Free Float
N/A
Market Cap
$2.38 billion
Optionable
Optionable
Beta
0.90
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:GHDX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners